Menu

Press release: TLA-based haplotyping to improve the quality of prenatal diagnostics

24 August 2017

The University Medical Center Utrecht and Hubrecht Institute have announced the publication in the American Journal of Human Genetics entitled "Sensitive Monogenic Noninvasive Prenatal Diagnosis by Targeted Haplotyping”.

 

The article describes how the use of TLA-based phasing of heterozygous variants of a gene of interest in parents, capture probes-based targeted sequencing of cfDNA from the pregnant mother, and a tailored statistical analysis enabling the prediction of fetal gene inheritance.

 

The article highlights the potential utility of TLA-based haplotyping to help improve the quality of prenatal genetic testing and/or genetic testing in combination with IVF.

 

 

VIEW PUBLICATION

 

 

More information

 

For more information about this development, visit:

www.hubrecht.eu/new-blood-test-prenatal-diagnosis

and

www.umcutrecht.nl/en/Research/News/New-blood-test-for-prenatal-screening

 

For more information about TLA-based sequencing and haplotyping, click here.

 

© 2012-2019 Cergentis B.V. All rights reserved.
For Research Use Only.Not for use in diagnostic procedures.
We use cookies for website analysis and marketing. By visiting and using our website you accept these cookies.
ACCEPT